We are live on ! Find out more
ACIM

Azimuth Capital Investment Management Portfolio holdings

AUM $2.96B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+32.75%
3 Year Est. Return
+103.21%
5 Year Est. Return
10 Year Est. Return
AUM
$2.42B
AUM Growth
+$205M
Cap. Flow
-$5.1M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.32%
Holding
317
New
15
Increased
105
Reduced
160
Closed
9

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$17.2M
2
RGA icon
Reinsurance Group of America
RGA
+$9.86M
3
GGG icon
Graco
GGG
+$9.48M
4
MRSH
Marsh
MRSH
+$9.07M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.63M

Sector Composition

Rank Sector Weight
1 Technology 26.89%
2 Healthcare 15.44%
3 Industrials 10.76%
4 Financials 10.45%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$440B
$15.7M 0.65%
86,312
-354
-0.4% -$61K
TYL icon
52
Tyler Technologies
TYL
$13B
$15.7M 0.65%
36,981
+18,445
+100% +$7.88M
TSM icon
53
TSMC
TSM
$2.23T
$14.1M 0.58%
103,627
-12,059
-10% -$1.5M
PEN icon
54
Penumbra
PEN
$12.9B
$14M 0.58%
62,650
-3,551
-5% -$878K
PFE icon
55
Pfizer
PFE
$150B
$13.4M 0.55%
484,072
+685
+0.1% +$19K
BA icon
56
Boeing
BA
$183B
$13.4M 0.55%
69,459
-53
-0.1% -$10.9K
DIS icon
57
Walt Disney
DIS
$178B
$13.3M 0.55%
108,813
-7,535
-6% -$787K
RMD icon
58
ResMed
RMD
$32.8B
$13.2M 0.54%
66,470
-310
-0.5% -$56.8K
EWJ icon
59
iShares MSCI Japan ETF
EWJ
$23.1B
$12.7M 0.53%
178,518
+623
+0.4% +$42.2K
GLOB icon
60
Globant
GLOB
$1.67B
$12.6M 0.52%
62,610
-214
-0.3% -$48.1K
PG icon
61
Procter & Gamble
PG
$335B
$12.6M 0.52%
77,452
-977
-1% -$153K
CVX icon
62
Chevron
CVX
$386B
$12.5M 0.52%
79,251
-167
-0.2% -$25.2K
WST icon
63
West Pharmaceutical
WST
$24.8B
$12.3M 0.51%
31,026
-1,536
-5% -$568K
MELI icon
64
Mercado Libre
MELI
$92.7B
$12.2M 0.51%
8,100
+75
+0.9% +$123K
GPN icon
65
Global Payments
GPN
$23.4B
$11.6M 0.48%
87,091
+2,588
+3% +$342K
ASML icon
66
ASML
ASML
$695B
$11.6M 0.48%
11,937
-39
-0.3% -$34.6K
CPAY icon
67
Corpay
CPAY
$26.9B
$11.4M 0.47%
36,980
-4,674
-11% -$1.34M
MRSH
68
Marsh
MRSH
$90.1B
$11.2M 0.46%
54,224
-45,510
-46% -$9.07M
ACN icon
69
Accenture
ACN
$110B
$11.1M 0.46%
31,906
+455
+1% +$166K
ZTS icon
70
Zoetis
ZTS
$30.4B
$11M 0.45%
65,037
-32,090
-33% -$6.01M
TGT icon
71
Target
TGT
$69.9B
$11M 0.45%
61,860
+2,825
+5% +$430K
INTU icon
72
Intuit
INTU
$91.6B
$10.9M 0.45%
16,825
+60
+0.4% +$38.3K
RGA icon
73
Reinsurance Group of America
RGA
$16.1B
$10.8M 0.45%
55,985
-56,523
-50% -$9.86M
ADP icon
74
Automatic Data Processing
ADP
$107B
$10.5M 0.44%
42,229
-575
-1% -$140K
CASY icon
75
Casey's General Stores
CASY
$31B
$10.5M 0.43%
32,843
+1,913
+6% +$559K

Similar funds

Azimuth Capital Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Azimuth Capital Investment Management held 317 positions worth $2.42B, up 9.2% from $2.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Azimuth Capital Investment Management's Q1 2024 filing shows 15 new, 105 increased, 160 reduced and 9 closed positions. Its largest new stake was Neurocrine Biosciences: 64,539 shares worth $8.9M. The largest sale was Broadcom, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Azimuth Capital Investment Management's largest Q1 2024 buy was Neurocrine Biosciences: 64,539 shares worth $8.9M.
  • Azimuth Capital Investment Management added most to Blackrock in Q1 2024, an estimated $15.9M increase.
  • Azimuth Capital Investment Management's biggest Q1 2024 reduction was Broadcom, cutting an estimated $17.2M.
  • Azimuth Capital Investment Management fully exited Graco in Q1 2024, selling an estimated $9.48M.
  • Azimuth Capital Investment Management's ten largest holdings make up 20% of its $2.42B portfolio in Q1 2024.
  • Azimuth Capital Investment Management opened 15 new positions and closed 9 in Q1 2024.
  • Azimuth Capital Investment Management's portfolio value rose 9.2% quarter-over-quarter to $2.42B.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2024, filed 14 May 2024.